XFOR logo

X4 Pharmaceuticals, Inc.

XFOR
Healthcare|Biotechnology|US
$3.18
+0.11 (+3.58%)
DCF Value
$20.28
Tangible Book / Share
$0.86
Cash / Share
$1.48

Ownership Breakdown

59.4%
Float
99.1M
Shares Outstanding
58.9M
Float Shares

Major Holders (40)

Combined: 300.7%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
Morgan Stanley Investment Management Inc.IA, CO10.20%8,884,304Mar 6, 202613D/G
Morgan StanleyHC, CO10.20%8,884,338Mar 6, 202613D/G
Ryan M. LaneHC, IN9.99%9,043,894Jan 15, 202613D/G
Empery Asset Management, LPIA, PN9.99%9,043,894Jan 15, 202613D/G
Hoe Martin D.HC, IN9.99%2,498,162Oct 21, 202513D/G
Lane Ryan M.HC, IN9.99%2,498,162Oct 21, 202513D/G
Coastlands Capital Partners LPPartnership9.99%2,491,638Oct 3, 202513D/G
Coastlands Capital LPIA, PN9.99%2,491,638Oct 3, 202513D/G
Matthew D. PerryHC, IN9.99%2,491,638Oct 3, 202513D/G
Coastlands Capital LLCHC, OO9.99%2,491,638Oct 3, 202513D/G
Coastlands Capital GP LLCOther9.99%2,491,638Oct 3, 202513D/G
David KroinHC, IN8.33%8,040,894Aug 14, 202613D/G
Deep Track Capital, LPIA, OO8.33%8,040,894Aug 14, 202613D/G
Joseph EdelmanIndividual8.10%8,085,006Aug 14, 202613D/G
Perceptive Life Sciences Master Fund, Ltd.Corporation8.10%8,085,006Aug 14, 202613D/G
Perceptive Advisors LLCInvestment adviser8.10%8,085,006Aug 14, 202613D/G
BCLS II Equity Opportunities, LPPartnership7.43%7,047,216Feb 17, 202613D/G
Xiaoying TianIndividual7.36%6,433,481Feb 17, 202613D/G
Saturn V Capital Management LPInvestment adviser7.36%6,433,481Feb 17, 202613D/G
Deep Track Biotechnology Master Fund, Ltd.Corporation7.18%6,923,680Aug 14, 202613D/G
Nea 18 Vge GP, LLCOther6.20%5,057,610Oct 29, 202513D/G
Growth Equity Opportunities 18 VGE, LLCOther6.20%5,057,610Oct 29, 202513D/G
NEA 18 Venture Growth Equity, L.P.Partnership6.20%5,057,610Oct 29, 202513D/G
NEA Partners 18 VGE, L.P.Partnership6.20%5,057,610Oct 29, 202513D/G
Ali BehbahaniIndividual6.20%5,057,610Oct 29, 202513D/G
Carmen ChangIndividual6.20%5,057,610Oct 29, 202513D/G
Anthony A. Florence, Jr.Individual6.20%5,057,610Oct 29, 202513D/G
Mohamad H. MakhzoumiIndividual6.20%5,057,610Oct 29, 202513D/G
Edward T. MathersIndividual6.20%5,057,610Oct 29, 202513D/G
Scott D. SandellIndividual6.20%5,057,610Oct 29, 202513D/G
Paul WalkerIndividual6.20%5,057,610Oct 29, 202513D/G
Rick YangIndividual6.20%5,057,610Oct 29, 202513D/G
BlackRock, Inc.Holding company5.90%5,529,573Jul 30, 202613D/G
Ortav YehudaiIndividual5.80%5,227,222Feb 17, 202613D/G
Trails Edge Biotechnology Master Fund, LPPartnership5.80%5,227,222Feb 17, 202613D/G
Trails Edge Capital Partners, LPIA, PN5.80%5,227,222Feb 17, 202613D/G
VHCP Management EG, LLCOther5.60%5,555,047Sep 21, 202613D/G
Bong Y. KohIndividual5.60%5,555,047Sep 21, 202613D/G
Nimish ShahIndividual5.60%5,555,047Sep 21, 202613D/G
VHCP Management III, LLCOther5.60%5,555,047Sep 21, 202613D/G

Insider Trades (100)

Last 4 quarters: 550,000 acquired · 109,283 disposed
InsiderPositionDateTypeSharesPriceValueFiling
Craig Adam Rdirector, officer: Executive ChairmanOct 16, 2026BUY4,600$2.58$11.9KForm 4
KIRSKE DAVIDChief Financial OfficerOct 1, 2026SELL11,767$2.86$33.7KForm 4
Volpone JohnPresidentAug 12, 2026SELL24,576$4.44$109.2KForm 4
Craig Adam Rdirector, officer: Executive ChairmanAug 12, 2026SELL47,436$4.44$210.8KForm 4
KIRSKE DAVIDChief Financial OfficerJun 30, 2026SELL8,543$4.26$36.4KForm 4
Gold KellydirectorJul 1, 2026AWARD110,000$4.08$449.4KForm 4
Gold Kellydirector: Jul 1, 2026OTHER0——Form 4
KIRSKE DAVIDChief Financial OfficerMay 12, 2026SELL16,961$4.29$72.8KForm 4
Bridger GarydirectorJan 1, 2026AWARD110,000$4.00$440.0KForm 4
de Craecker FrancoisedirectorJan 1, 2026AWARD110,000$4.00$440.0KForm 4
WYZGA MICHAEL SdirectorJan 1, 2026AWARD110,000$4.00$440.0KForm 4
Stewart MurraydirectorJan 1, 2026AWARD110,000$4.00$440.0KForm 4
Craig Adam Rdirector, officer: Executive ChairmanOct 29, 2025AWARD2,329,154$1.42$3.3MForm 4
Volpone JohnPresidentOct 29, 2025AWARD2,329,154$1.42$3.3MForm 4
KIRSKE DAVIDChief Financial OfficerOct 29, 2025AWARD1,552,769$1.42$2.2MForm 4
Craig Adam Rdirector, officer: Executive ChairmanOct 23, 2025BUY86,206$2.90$250.0KForm 4
Volpone JohnPresidentAug 12, 2025AWARD1,609,873$1.42$2.3MForm 4
Volpone JohnPresidentAug 14, 2025AWARD529,201$3.14$1.7MForm 4
Volpone JohnPresidentAug 14, 2025AWARD289,881——Form 4
Craig Adam Rdirector, officer: Executive ChairmanAug 12, 2025OTHER0——Form 4
KIRSKE DAVIDofficerAug 12, 2025OTHER0——Form 4
Craig Adam Rdirector, officer: Executive ChairmanAug 12, 2025AWARD1,609,873$1.42$2.3MForm 4
Craig Adam Rdirector, officer: Executive ChairmanAug 14, 2025AWARD529,201$3.14$1.7MForm 4
Craig Adam Rdirector, officer: Executive ChairmanAug 14, 2025AWARD289,881——Form 4
KIRSKE DAVIDChief Financial OfficerAug 12, 2025AWARD1,073,249$1.42$1.5MForm 4
KIRSKE DAVIDChief Financial OfficerAug 14, 2025AWARD352,800$3.14$1.1MForm 4
KIRSKE DAVIDChief Financial OfficerAug 14, 2025AWARD193,254——Form 4
Volpone JohnofficerAug 12, 2025OTHER0——Form 4
Thoren Natasha FayChief Legal OfficerMay 20, 2025AWARD3,333——Form 4
Stewart MurraydirectorJun 9, 2025AWARD1,500——Form 4
de Craecker FrancoisedirectorJun 9, 2025AWARD1,500——Form 4
Bridger GarydirectorJun 9, 2025AWARD1,500——Form 4
Woods KeithdirectorJun 9, 2025AWARD1,500——Form 4
MCGIRR DAVID W JdirectorJun 9, 2025AWARD1,500——Form 4
WYZGA MICHAEL SdirectorJun 9, 2025AWARD1,500——Form 4
Thoren Natasha FayChief Legal OfficerMay 20, 2025OTHER0——Form 4
Thoren Natasha FayChief Legal OfficerMay 20, 2025OTHER8,166$32.70$267.0KForm 4
Baldry MarkChief Commercial OfficerMay 16, 2025AWARD1,032$2.48$2.6KForm 4
Baldry MarkChief Commercial OfficerMay 16, 2025BUY1,032$2.48$2.6KForm 4
Arbet-Engels ChristopheChief Medical OfficerFeb 12, 2025AWARD850,000——Form 4
Mostafa Adam S.Chief Financial OfficerFeb 12, 2025AWARD850,000——Form 4
Ragan Pauladirector, officer: President and CEOFeb 12, 2025AWARD2,250,000——Form 4
Baldry MarkChief Commercial OfficerFeb 12, 2025AWARD600,000——Form 4
Baldry MarkChief Commercial OfficerNov 15, 2024BUY13,404$0.34$4.6KForm 4
Baldry MarkChief Commercial OfficerMay 17, 2024BUY21,646$0.68$14.7KForm 4
DiBiase MaryChief Operating OfficerFeb 12, 2025AWARD650,000——Form 4
Ragan Pauladirector, officer: President and CEOJan 23, 2025AWARD169,940——Form 4
Ragan Pauladirector, officer: President and CEOJan 24, 2025SELL76,473$0.45$34.7KForm 4
Mostafa Adam S.Chief Financial OfficerJan 23, 2025AWARD74,773——Form 4
Mostafa Adam S.Chief Financial OfficerJan 24, 2025SELL74,773$0.45$33.9KForm 4
Baldry MarkChief Commercial OfficerJan 23, 2025AWARD74,773——Form 4
Baldry MarkChief Commercial OfficerJan 24, 2025SELL29,159$0.45$13.2KForm 4
DiBiase MaryChief Operating OfficerJan 23, 2025AWARD61,178——Form 4
DiBiase MaryChief Operating OfficerJan 24, 2025SELL22,258$0.45$10.1KForm 4
Arbet-Engels ChristopheChief Medical OfficerJan 23, 2025AWARD25,831——Form 4
Arbet-Engels ChristopheChief Medical OfficerJan 24, 2025SELL11,624$0.45$5.3KForm 4
Ragan Pauladirector, officer: President and CEONov 15, 2024SELL31,897$0.39$12.6KForm 4
Ragan Pauladirector, officer: President and CEOOct 15, 2024SELL31,897$0.56$17.9KForm 4
Mostafa Adam S.Chief Financial OfficerOct 4, 2024AWARD230,645——Form 4
Mostafa Adam S.Chief Financial OfficerOct 7, 2024SELL230,645$0.55$126.9KForm 4
Baldry MarkChief Commercial OfficerOct 4, 2024AWARD34,946——Form 4
Baldry MarkChief Commercial OfficerOct 7, 2024SELL11,127$0.58$6.5KForm 4
Ragan Pauladirector, officer: President and CEOOct 4, 2024AWARD532,081——Form 4
Ragan Pauladirector, officer: President and CEOOct 7, 2024SELL239,436$0.55$131.5KForm 4
DiBiase MaryChief Operating OfficerOct 4, 2024AWARD230,645——Form 4
DiBiase MaryChief Operating OfficerOct 7, 2024SELL67,695$0.57$38.3KForm 4
Taveras ArthurChief Scientific OfficerOct 4, 2024AWARD230,645——Form 4
Taveras ArthurChief Scientific OfficerOct 7, 2024SELL76,920$0.56$43.3KForm 4
DiBiase MaryChief Operating OfficerSep 9, 2024SELL2,642$0.66$1.7KForm 4
de Craecker FrancoisedirectorJun 10, 2024AWARD45,000——Form 4
Aliski WilliamdirectorJun 10, 2024AWARD45,000——Form 4
MCGIRR DAVID W JdirectorJun 10, 2024AWARD45,000——Form 4
Stewart MurraydirectorJun 10, 2024AWARD45,000——Form 4
Bridger GarydirectorJun 10, 2024AWARD45,000——Form 4
Woods KeithdirectorJun 10, 2024AWARD45,000——Form 4
Lawton Alison FrancesdirectorJun 10, 2024AWARD45,000——Form 4
WYZGA MICHAEL SdirectorJun 10, 2024AWARD45,000——Form 4
Taveras ArthurChief Scientific OfficerMar 11, 2024SELL14,235$0.88$12.6KForm 4
Ragan Pauladirector, officer: President and CEOMar 11, 2024SELL49,678$0.88$43.9KForm 4
Mostafa Adam S.Chief Financial OfficerMar 11, 2024SELL52,500$0.88$46.3KForm 4
DiBiase MaryChief Operating OfficerMar 11, 2024SELL15,409$0.88$13.6KForm 4
Arbet-Engels ChristopheChief Medical OfficerFeb 13, 2024AWARD180,816$0.92$166.5KForm 4
Arbet-Engels ChristopheChief Medical OfficerFeb 13, 2024AWARD475,831$0.92$438.2KForm 4
Mostafa Adam S.Chief Financial OfficerFeb 13, 2024AWARD523,414$0.92$482.1KForm 4
DiBiase MaryChief Operating OfficerFeb 13, 2024AWARD428,248$0.92$394.4KForm 4
Ragan Pauladirector, officer: President and CEOFeb 13, 2024AWARD1,189,578$0.92$1.1MForm 4
Baldry MarkChief Commercial OfficerFeb 13, 2024AWARD523,414$0.92$482.1KForm 4
Taveras ArthurChief Scientific OfficerFeb 13, 2024AWARD428,248$0.92$394.4KForm 4
DiBiase MaryChief Operating OfficerFeb 12, 2024SELL3,683$1.01$3.7KForm 4
Taveras ArthurChief Scientific OfficerFeb 12, 2024SELL787$1.01$792.67Form 4
Ragan Pauladirector, officer: President and CEOFeb 12, 2024SELL21,695$1.01$21.9KForm 4
Mostafa Adam S.Chief Financial OfficerFeb 12, 2024SELL27,721$1.01$28.0KForm 4
Ragan Pauladirector, officer: President and CEONov 1, 2023SELL199,531$0.73$145.7KForm 4
Ragan Pauladirector, officer: President and CEONov 3, 2023SELL39,906$0.90$35.9KForm 4
Mostafa Adam S.Chief Financial OfficerNov 1, 2023SELL230,645$0.73$168.4KForm 4
DiBiase MaryChief Operating OfficerNov 1, 2023SELL67,695$0.73$49.4KForm 4
Baldry MarkChief Commercial OfficerNov 1, 2023SELL10,257$0.73$7.5KForm 4
Taveras ArthurChief Scientific OfficerNov 1, 2023SELL67,695$0.73$49.4KForm 4
Mostafa Adam S.Chief Financial OfficerOct 31, 2023AWARD230,645——Form 4
Baldry MarkChief Commercial OfficerOct 31, 2023AWARD34,947——Form 4